CCM
CVS icon

Copernicus Capital Management’s CVS Health CVS Stock Holding History

Copernicus Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-130,000
Closed -$7.71M – 22
2020
Q1 		$7.71M Buy
+130,000
New +$8.68M 9.33% 5
2019
Q1 		– Sell
-59,956
Closed -$3.93M – 15
2018
Q4 		$3.93M Sell
59,956
-80,053
-57% -$5.98M 7.39% 7
2018
Q3 		$11M Buy
140,009
+4,414
+3% +$316K 10.35% 5
2018
Q2 		$8.73M Buy
+135,595
New +$8.94M 6.33% 7

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Copernicus Capital Management's CVS Position: Q2 2020 in Review

Copernicus Capital Management sold out of CVS Health (CVS) in Q2 2020, closing a stake of 130,000 shares — an estimated $7.71M sold.

Copernicus Capital Management first reported a position in CVS in Q2 2018 and held it in 4 quarters. The position peaked at $11M in Q3 2018. 1,863 funds tracked by Wall St. Rank hold CVS as of Q2 2020.

  • Copernicus Capital Management reported no remaining CVS Health position as of Q2 2020 after selling out during the quarter.
  • Copernicus Capital Management sold 130,000 CVS Health shares in Q2 2020, an estimated $7.71M.
  • Copernicus Capital Management first reported a position in CVS Health in Q2 2018 and held it in 4 quarters.
  • Copernicus Capital Management's CVS Health position peaked at $11M in Q3 2018.
  • 1,863 funds tracked by Wall St. Rank held CVS Health as of Q2 2020.

Based on Copernicus Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.